Michael Ackermann
Director, Oyster Point Pharma, Inc.
Companies
- Tarsus Pharmaceuticals, Inc.Board member Oct 15, 2020 to Jul 1, 20221
- Oyster Point Pharma, Inc.Board member Oct 30, 2019 to Jun 10, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS1,308,273 shares3$97.6M at $74.57Jun 17, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 15, 2022Exercised options 4,257 shares of Tarsus Pharmaceuticals, Inc.3
- May 5, 2022Bought 100,000 shares at $13.50 of Tarsus Pharmaceuticals, Inc.4
- Dec 1, 2021Sold 528 shares at $26.65 of Tarsus Pharmaceuticals, Inc.5
- Dec 1, 2021Sold 809 shares at $25.87 of Tarsus Pharmaceuticals, Inc.5
- Dec 1, 2021Sold 2,054 shares at $24.68 of Tarsus Pharmaceuticals, Inc.5
- Dec 1, 2021Sold 2,442 shares at $23.85 of Tarsus Pharmaceuticals, Inc.5
- Nov 1, 2021Sold 869 shares at $28.18 of Tarsus Pharmaceuticals, Inc.6
- Nov 1, 2021Sold 4,964 shares at $27.76 of Tarsus Pharmaceuticals, Inc.6
- Oct 12, 2021Sold 4,517 shares at $26.45 of Tarsus Pharmaceuticals, Inc.7
- Oct 12, 2021Sold 1,116 shares at $25.56 of Tarsus Pharmaceuticals, Inc.7
- Oct 8, 2021Sold 200 shares at $25.03 of Tarsus Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 9, 2022
- 5SEC EDGARForm 4 filed Dec 3, 2021
- 6SEC EDGARForm 4 filed Nov 3, 2021
- 7SEC EDGARForm 4 filed Oct 14, 2021
- 8SEC EDGARForm 4 filed Oct 12, 2021